Cite
APA Citation
Umeda, N., Matsumoto, I., Inoue, A., Tanaka, Y., Takai, C., Kurashima, Y., Kondo, Y., Tsuboi, H., Ogishima, H., Suzuki, T., & Sumida, T. (2014). aB0136 Clinical Aspects and Pathogenicity of Anti-Cyclic Citrullinated Glucose-6-Phospate Isomerase Peptide (CCG) Antibodies in Patients with Rheumatoid Arthritis. Annals of the rheumatic diseases, 73, 848. http://access.bl.uk/ark:/81055/vdc_100135138864.0x00005c